Cancer revoked: oncogenes as therapeutic targets (Q35118737)

6 August 2017

1 reference

title

Cancer revoked: oncogenes as therapeutic targets (English)

1 reference

6 August 2017

Dean W. Felsher

1

1 reference

PubMed ID

12724735

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12724735

29 December 2023

language of work or name

English

0 references

publication date

1 May 2003

1 reference

PubMed ID

12724735

full work available at URL

6 August 2017

http://www.nature.com/articles/nrc1070

1 reference

https://api.crossref.org/works/10.1038/NRC1070

http://www.nature.com/articles/nrc1070.pdf

29 December 2023

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/NRC1070

29 December 2023

published in

Nature Reviews Cancer

1 reference

6 August 2017

3

1 reference

6 August 2017

5

1 reference

6 August 2017

375-380

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc1070

6 August 2017

0 references

cites work

Essential role for oncogenic Ras in tumour maintenance

1 reference

Reversible tumorigenesis by MYC in hematopoietic lineages

31 March 2020

1 reference

Sustained loss of a neoplastic phenotype by brief inactivation of MYC

31 March 2020

1 reference

Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion

31 March 2020

1 reference

Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression.

31 March 2020

1 reference

Reversibility of acute B-cell leukaemia induced by BCR-ABL1.

31 March 2020

1 reference

c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations

31 March 2020

1 reference

Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes

31 March 2020

1 reference

Disabling Abl-perspectives on Abl kinase regulation and cancer therapeutics

31 March 2020

1 reference

Finding the next Gleevec: FLT3 targeted kinase inhibitor therapy for acute myeloid leukemia

31 March 2020

1 reference

Cancer. Addiction to oncogenes--the Achilles heal of cancer

31 March 2020

1 reference

Transcriptional activation by tetracyclines in mammalian cells

31 March 2020

1 reference

Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice

31 March 2020

1 reference

Genomically complex lymphomas undergo sustained tumor regression upon MYC inactivation unless they acquire novel chromosomal translocations

31 March 2020

1 reference

Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen

31 March 2020

1 reference

Transient excess of MYC activity can elicit genomic instability and tumorigenesis

31 March 2020

1 reference

Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis

31 March 2020

1 reference

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

31 March 2020

1 reference

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

31 March 2020

1 reference

Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study

31 March 2020

1 reference

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

31 March 2020

1 reference

Molecular mechanisms of resistance to STI571 in chronic myeloid leukemia

31 March 2020

1 reference

Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia

31 March 2020

1 reference

Differentiation-linked leukemogenesis in lymphocytes

31 March 2020

1 reference

Effect of oncogenic virus on muscle differentiation

31 March 2020

1 reference

Infection of chick limb bud presumptive chondroblasts by a temperature-sensitive mutant of Rous sarcoma virus and the reversible inhibition of their terminal differentiation in culture

31 March 2020

1 reference

Cancer epigenetics and methylation

31 March 2020

1 reference

DNMT1 and DNMT3b cooperate to silence genes in human cancer cells

31 March 2020

1 reference

Cancer chemopreventive activity of resveratrol, a natural product derived from grapes

31 March 2020

1 reference

Mutations and altered expression of p16INK4 in human cancer.

31 March 2020

1 reference

Medulloblastoma growth inhibition by hedgehog pathway blockade

31 March 2020

1 reference

Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor

31 March 2020

1 reference

A complex with chromatin modifiers that occupies E2F- and Myc-responsive genes in G0 cells

31 March 2020

1 reference

Role of DNA 5-methylcytosine transferase in cell transformation by fos

31 March 2020

1 reference

c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression

31 March 2020

1 reference

All-trans-retinoic acid in acute promyelocytic leukemia

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRC1070

1 reference

6 August 2017

1 reference

PubMed ID

12724735